News

Infosheet on international cooperation in Horizon Europe

Published on | 4 years ago

Programmes Horizon Europe HorizonEU L+F

International cooperation in research and innovation remains a very important strategic priority for Europe. The  Horizon Europe programme is therefore not only limited to participants from EU Member States but is also open to participants from non-EU countries.

NCP Flanders has created an infosheet on international cooperation in Horizon Europe where you can find more information on the different ways and forms on how you can involve partners from non-EU countries in a Horizon Europe project based on the information that is available today. You can find the infosheet here. It will be updated as soon as new information becomes available.

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1651 articles available search in articles 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.